• Je něco špatně v tomto záznamu ?

Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone

L. Sanchez, X. Leleu, JL. Beaumont, H. Yu, S. Hudgens, M. Simonova, HW. Auner, H. Quach, S. Delimpasi, I. Špička, L. Pour, I. Kriachok, MA. Dimopoulos, G. Usenko, R. Hájek, R. Benjamin, DK. Sinha, C. Venner, T. Illmer, MK. Garg, DA. Stevens, S....

. 2021 ; 96 (10) : E383-E386. [pub] 20210712

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, fáze III, dopisy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024892

1st Internal Clinic Clinic of Hematology General University Hospital Prague Prague Czechia

Baylor University Medical Center Dallas Texas USA

CHU de Poitiers Hôpital La Milétrie Service d'Hématologie et Thérapie Cellulaire Pôle Régional de Cancérologie Poitiers France

CHU Lille Service des Maladies du Sang Lille France

City Clinical Hospital No 4 of Dnipro City Council City Hematology Center Dnipro Ukraine

Clinical Outcomes Solutions Tucson Arizona USA

Cross Cancer Institute University of Alberta Edmonton Alberta Canada

Dana Farber Cancer Institute Boston Massachusetts USA

Department of Clinical Therapeutics National and Kapodistrian University of Athens School of Medicine Alexandra General Hospital Athens Greece

Department of Hemato oncology University Hospital Ostrava Ostrava Czechia

Evangelismos Hospital Hematology Lymphomas and BMT Unit Athens Greece

Group Practice for Hematology and Oncology Dresden Germany

Hugh and Josseline Langmuir Centre for Myeloma Research Imperial College London London UK

Icahn School of Medicine at Mount Sinai New York New York USA

Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine Lviv Ukraine

Karyopharm Therapeutics Newton Massachusetts USA

Kings College Hospital NHS Foundation Trust London UK

Medical University of Silesia Katowice Poland

Norton Cancer Institute St Matthews Louisville Kentucky USA

Policlinico S Orsola Malpighi Bologna Italy

Scientific Research Department of Chemotherapy of Hemoblastoses and Adjuvant Treatment Methods National Cancer Institute Rockville Maryland USA

Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas USA

St Vincent's Hospital University of Melbourne Melbourne Victoria Australia

State Cancer Institute Indira Gandhi Institute of Medical Sciences Patna India

University Hospital Brno Clinic of Internal Medicine Hematology and Oncology Brno Czechia

University Hospitals of Leicester NHS Trust Leicester UK

University of Calgary Charbonneau Cancer Research Institute Calgary Alberta Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024892
003      
CZ-PrNML
005      
20211026134311.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ajh.26282 $2 doi
035    __
$a (PubMed)34161627
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sanchez, Larysa $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
245    10
$a Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone / $c L. Sanchez, X. Leleu, JL. Beaumont, H. Yu, S. Hudgens, M. Simonova, HW. Auner, H. Quach, S. Delimpasi, I. Špička, L. Pour, I. Kriachok, MA. Dimopoulos, G. Usenko, R. Hájek, R. Benjamin, DK. Sinha, C. Venner, T. Illmer, MK. Garg, DA. Stevens, S. Jagannath, M. Levy, LD. Anderson, NJ. Bahlis, T. Facon, M. Cavo, Y. Chai, X. Ma, S. Tang, H. Leong, J. Shah, S. Shacham, M. Kauffman, P. Richardson, S. Grosicki
650    _2
$a senioři $7 D000368
650    _2
$a protokoly protinádorové kombinované chemoterapie $x škodlivé účinky $x terapeutické užití $7 D000971
650    _2
$a bortezomib $x škodlivé účinky $x terapeutické užití $7 D000069286
650    _2
$a dexamethason $x škodlivé účinky $x terapeutické užití $7 D003907
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hydraziny $x škodlivé účinky $x terapeutické užití $7 D006834
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mnohočetný myelom $x farmakoterapie $7 D009101
650    _2
$a bolest $x chemicky indukované $7 D010146
650    _2
$a nemoci periferního nervového systému $x chemicky indukované $7 D010523
650    _2
$a triazoly $x škodlivé účinky $x terapeutické užití $7 D014230
655    _2
$a klinické zkoušky, fáze III $7 D017428
655    _2
$a dopisy $7 D016422
700    1_
$a Leleu, Xavier $u CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Poitiers, France
700    1_
$a Beaumont, Jennifer L $u Clinical Outcomes Solutions, Tucson, Arizona, USA
700    1_
$a Yu, Hailin $u Clinical Outcomes Solutions, Tucson, Arizona, USA
700    1_
$a Hudgens, Stacie $u Clinical Outcomes Solutions, Tucson, Arizona, USA
700    1_
$a Simonova, Maryana $u Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine
700    1_
$a Auner, Holger W $u Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College London, London, UK
700    1_
$a Quach, Hang $u St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia
700    1_
$a Delimpasi, Sosana $u Evangelismos Hospital, Hematology/Lymphomas and BMT Unit, Athens, Greece
700    1_
$a Špička, Ivan $u 1st Internal Clinic - Clinic of Hematology, General University Hospital in Prague, Prague, Czechia
700    1_
$a Pour, Ludĕk $u University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czechia
700    1_
$a Kriachok, Iryna $u Scientific Research Department of Chemotherapy of Hemoblastoses and Adjuvant Treatment Methods, National Cancer Institute, Rockville, Maryland, USA
700    1_
$a Dimopoulos, Meletios A $u Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
700    1_
$a Usenko, Ganna $u City Clinical Hospital No.4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
700    1_
$a Hájek, Roman $u Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czechia
700    1_
$a Benjamin, Reuben $u Kings College Hospital NHS Foundation Trust, London, UK
700    1_
$a Sinha, Dinesh Kumar $u State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India
700    1_
$a Venner, Christopher $u Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Illmer, Thomas $u Group Practice for Hematology and Oncology, Dresden, Germany
700    1_
$a Garg, Mamta Krishnan $u University Hospitals of Leicester NHS Trust, Leicester, UK
700    1_
$a Stevens, Don Ambrose $u Norton Cancer Institute- St. Matthews, Louisville, Kentucky, USA
700    1_
$a Jagannath, Sundar $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Levy, Moshe $u Baylor University Medical Center, Dallas, Texas, USA
700    1_
$a Anderson, Larry D $u Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA
700    1_
$a Bahlis, Nizar Jacques $u University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada
700    1_
$a Facon, Thierry $u CHU Lille Service des Maladies du Sang, Lille, France
700    1_
$a Cavo, Michele $u Policlinico S. Orsola-Malpighi, Bologna, Italy
700    1_
$a Chai, Yi $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Ma, Xiwen $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Tang, Shijie $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Leong, Hoyee $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Shah, Jatin $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Shacham, Sharon $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Kauffman, Michael $u Karyopharm Therapeutics, Newton, Massachusetts, USA
700    1_
$a Richardson, Paul $u Dana-Farber Cancer Institute, Boston, Massachusetts, USA
700    1_
$a Grosicki, Sebastian $u Medical University of Silesia, Katowice, Poland
773    0_
$w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 96, č. 10 (2021), s. E383-E386
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34161627 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026134317 $b ABA008
999    __
$a ok $b bmc $g 1714095 $s 1145399
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 96 $c 10 $d E383-E386 $e 20210712 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace